Hong Kong IPO market ends strongly: Six mainland companies go public together, raising $900 million in a single day.

```

Hong Kong's stock market concluded its year of recovery with a round of intensive listing activity.

On Tuesday, six mainland Chinese companies debuted for trading in Hong Kong, raising a total of approximately HK$6.99 billion (about US$900 million). This not only strengthened Hong Kong's status as Asia's top listing destination, but also set the tone for the market outlook in 2026.

According to data from the London Stock Exchange Group (LSEG), the total amount of funds raised in Hong Kong through share offerings (including IPOs and follow-on offerings) in 2025 is expected to reach about US$75 billion, more than triple that of 2024 and the highest level since 2021. This figure marks Hong Kong's strong comeback in global capital markets, re-establishing its leading position as Asia's equity capital market center.

On Tuesday, five of the six newly-listed companies started trading above their issue price and generally maintained gains throughout the session without significant volatility. This robust performance reflects a recovery in investor confidence, especially given regulatory adjustments and ample liquidity, with the market remaining optimistic about technology-driven growth prospects. Market participants widely believe that this positive momentum will extend into 2026.

George Au, Deputy Sales Director at Phillip Securities, pointed out that this has been the best performing year since the suspension of the Ant Group IPO. He believes the boom in margin lending, previously successful listings such as Mixue Bingcheng and CATL, and the allocation rule adjustments in August aimed at curbing excessive retail speculation have together boosted market sentiment.

Divergent First-Day Performance: AI and Tech Stocks Lead

The six companies listed on Tuesday span artificial intelligence, software, industrial manufacturing, and consumer goods, with technology stocks standing out particularly.

Generative AI drug development company Insilico Medicine surged about 45% at the open, leading the new stocks. Software company 51 Vision opened up nearly 15%, and industrial steel structure manufacturer Midland Holdings rose more than 15%. In addition, premium skincare brand Forest Cabin climbed about 9%.

The other two companies were relatively steady: Xunce and Wohan Robotics opened flat. George Au said that the market atmosphere remains favorable as the year ends, with no obvious signs of cooling, and investors are currently showing more caution and rationality.

New Issue Relay: Projects Over HK$9 Billion Launched

While six companies commenced trading, another three Chinese firms launched share offerings in Hong Kong on Tuesday, bringing in new IPO fundraisings exceeding HK$9.22 billion, with all three planning to list on January 8.

Specifically, Zhipu AI (Knowledge Graph Technology Co., Ltd.) plans to offer 37.42 million H shares, priced at HK$116.20 per share, aiming to raise HK$4.35 billion. Chipmaker Shanghai TianShu Zhixin Semiconductor is offering 25.4 million shares at HK$144.60 each, raising HK$3.67 billion. Surgical robot manufacturer Shenzhen Jingfeng Medical Technology Co., Ltd. plans to sell 27.72 million shares at HK$43.24 per share, raising about HK$1.2 billion.

Outlook for 2026: Over 300 Companies Lined Up to List

This round of intensive listings and new share offerings highlight Hong Kong's revival as an IPO hub. More than 300 companies have already submitted listing applications, suggesting this trend is likely to extend into 2026.

The market will next turn its attention to the scheduled listing of Shanghai Biren Technology Co., Ltd. on January 2. Analysts note the company's debut may set the market tone for 2026. In addition, Shanghai Xiyu Technology in the AI sector is also still preparing for its IPO. IPO applications from AI and tech enterprises are set to dominate early 2026 market supply.

Risk Warning and DisclaimerThe market contains risks and investment requires caution. This article does not constitute personal investment advice, nor does it take into account individual users' specific investment objectives, financial situations, or needs. Users should consider whether any opinions, views or conclusions in this article suit their particular circumstances. Investing accordingly is at your own risk. ```